Acadia Pharmaceuticals | ACAD - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Acadia Pharmaceuticals USD 956.47M 105.02M 2026-06
ALKERMES USD 511.53M 159.98M 2026-06
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Cara Therapeutics USD 19.85M 883K 2026-03
Corcept Therapeutics USD 111.04M 2.3M 2026-06
Cytokinetics USD 255.27M 125.43M 2026-06
Eisai JPY 245.42B 56.22B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Incyte USD 3.98B 33.45M 2026-06
J&J USD 20.42B 1.27B 2026-06
Moderna USD 1.72B 185M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Pfizer USD 976M 727M 2026-06
Prothena USD 288.19M 41.27M 2026-06
PTC Therapeutics USD 1.05B 215.9M 2026-06
Sarepta Therapeutics USD 571.15M 106.7M 2026-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Vertex Pharmaceuticals USD 7.85B 605.7M 2026-06